0001125376-21-000126.txt : 20210728 0001125376-21-000126.hdr.sgml : 20210728 20210728161120 ACCESSION NUMBER: 0001125376-21-000126 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20210728 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210728 DATE AS OF CHANGE: 20210728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENSIGN GROUP, INC CENTRAL INDEX KEY: 0001125376 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SKILLED NURSING CARE FACILITIES [8051] IRS NUMBER: 330861263 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33757 FILM NUMBER: 211122654 BUSINESS ADDRESS: STREET 1: 29222 RANCHO VIEJO RD. STREET 2: SUITE 127 CITY: SAN JUAN CAPISTRANO STATE: CA ZIP: 92675 BUSINESS PHONE: (949) 487-9500 MAIL ADDRESS: STREET 1: 29222 RANCHO VIEJO RD. STREET 2: SUITE 127 CITY: SAN JUAN CAPISTRANO STATE: CA ZIP: 92675 FORMER COMPANY: FORMER CONFORMED NAME: ENSIGN GROUP INC DATE OF NAME CHANGE: 20000930 8-K 1 ensg-20210728.htm 8-K ensg-20210728
0001125376false00011253762021-07-282021-07-28

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 28, 2021
The Ensign Group, Inc.
(Exact name of registrant as specified in its charter)
     
Delaware 001-33757 33-0861263
     
(State or other jurisdiction
of incorporation)
 (Commission File Number) (IRS Employer Identification No.)
29222 Rancho Viejo Road, Suite 127, 
San Juan Capistrano,CA92675
   
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (949) 487-9500
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per shareENSGNasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 2.02. Results of Operations and Financial Condition.
On July 28, 2021 The Ensign Group, Inc. (the Company) issued a press release reporting the financial results of the Company for its second quarter ended June 30, 2021. A copy of the press release is attached to this Current Report as Exhibit 99.1.
The press release includes “non-GAAP financial measures.” Specifically, the press release refers to EBITDA, Adjusted EBITDA, Adjusted EBITDAR and Funds from Operations (FFO) for our real estate segment. EBITDA, Adjusted EBITDA, Adjusted EBITDAR and FFO are supplemental non-GAAP financial measures. Regulation G, Conditions for Use of Non-GAAP Financial Measures, and other provisions of the Securities Exchange Act of 1934, as amended, define and prescribe the conditions for use of certain non-GAAP financial information. EBITDA consists of net income before (a) interest expense, net, (b) provisions for income taxes and (c) depreciation and amortization. Adjusted EBITDA consists of net income before (a) interest expense, net, (b) provisions for income taxes, (c) depreciation and amortization, (d) stock-based compensation expense; (e) results of operations not at full capacity, excluding depreciation, interest and income taxes, (f) acquisition related costs, (g) gain on sale of assets, (h) costs incurred related to real estate due diligence and (i) costs incurred related to new systems implementation. Adjusted EBITDAR consists of net income before (a) interest expense, net, (b) provisions for income taxes, (c) depreciation and amortization, (d) rent-cost of services, (e) stock-based compensation expense; (f) results of operations not at full capacity, excluding rent, depreciation, interest and income taxes, (g) acquisition related costs, (h) gain on sale of assets, (i) costs incurred related to real estate due diligence and (j) costs incurred related to new systems implementation. Funds from Operations (FFO) for our real estate segment consists of segment income, excluding gains or losses from sales of real estate, insurance recoveries related to real estate and impairment of depreciable real estate assets and including depreciation and amortization related to real estate to earnings. The company believes that the presentation of EBITDA, adjusted EBITDA, FFO, adjusted net income and adjusted earnings per share provides important supplemental information to management and investors to evaluate the company’s operating performance. Adjusted EBITDAR is a financial valuation measure that is not specified in GAAP. This measure is not displayed as a performance measure as it excludes rent expense, which is a normal and recurring operating expense. The company believes disclosure of adjusted net income, adjusted net income per share, FFO, EBITDA, adjusted EBITDA and adjusted EBITDAR has substance because the excluded revenues and expenses are infrequent in nature and are variable in nature, or do not represent current revenues or cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the company believes that this non-GAAP measures provide useful information to investors, the specific manner in which management uses these measures, and some of the limitations associated with the use of these measures, please refer to the company's periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The company’s periodic filings are available on the SEC's website at www.sec.gov or under the "Financial Information" link of the Investor Relations section on Ensign’s website at http://www.ensigngroup.net.








Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
   
Exhibit No. Description
   
 
Press Release of the Company dated July 28, 2021
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
Dated: July 28, 2021
THE ENSIGN GROUP, INC. 
 By:  /s/ Suzanne D. Snapper   
  Suzanne D. Snapper  
  Chief Financial Officer and Executive Vice President (principal financial officer and accounting officer and duly authorized officer) 
 


EX-99.1 2 q22021pressrelease.htm EX-99.1 Document


ensigngrouplogoa02a01a34.gif

The Ensign Group Reports Second Quarter 2021 Results

Conference Call and Webcast scheduled for tomorrow, July 29, 2021 at 10:00 am PT
SAN JUAN CAPISTRANO, California – July 28, 2021 – The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of companies, which provide post-acute healthcare services and invest in the long-term healthcare industry, primarily in skilled nursing and senior living facilities, announced record operating results for the second quarter of 2021, reporting GAAP diluted earnings per share of $0.87 for the quarter ended June 30, 2021. Ensign also reported a record adjusted earnings per share of $0.89 for the quarter(1).

Highlights Include:

GAAP diluted earnings per share for the quarter was $0.87, representing an increase of 19.2% over the prior year quarter. Adjusted diluted earnings per share for the quarter was $0.89, an increase of 14.1%(1) over the prior year quarter.

Consolidated GAAP revenues and adjusted revenues(1) for the quarter were both $638.5 million, an increase of 9.2% and 9.3% over the prior year quarter, respectively.

Total skilled services(2) segment income increased to $90.0 million or 15.0% compared to prior year quarter.

Real estate(2) segment income was $8.9 million for the quarter, an increase of 14.1% from prior year quarter and FFO was $13.7 million for the quarter, an increase of 10.5% over the prior year quarter.

Same store and transitioning skilled revenue improved by 4.2% and 7.4%, respectively, over the prior year quarter with an increase in skilled mix days of 1.4% and 2.9%, respectively.

Same store and transitioning occupancy increased by 1.7% and 1.5%, respectively, both sequentially over the first quarter.

Same store and transitioning managed care revenue improved by 36.3% and 28.6%, respectively; with managed care census increasing by 33.9% and 27.9%, respectively, over the prior year quarter.

GAAP net income was $49.4 million for the quarter, an increase of 22.8% from prior year quarter. Adjusted net income was $50.9 million for the quarter, an increase of 18.0%(1) over the prior year quarter.


(1) See "Reconciliation of GAAP to Non-GAAP Financial Information".
(2) Our Skilled Services and Real Estate Segments are defined and outlined in Note 7 on Form 10-Q.


Operating Results

“We are very happy to report another record quarter. As the healthcare system continued its march toward normalcy, we continued to see patient flows trending towards traditional patterns and the momentum we saw in occupancies during the first quarter continued into the second. In fact, from the low point of our pandemic period census, which we hit in December of 2020, our same store and transitioning operations have already improved census by 51.6%. We were particularly pleased that we achieved sequential growth in occupancies from the first to the second quarter, which is especially impressive given we always expect a seasonal decrease in occupancies in the summer months,” said Barry Port, Ensign’s Chief Executive Officer. “The solid results were achieved by our locally-empowered leadership teams who worked tirelessly to remain an integral part of the healthcare continuum during the pandemic. We are pleased to see that those efforts are being rewarded by their hospital and managed care partners, who have and continue to entrust our operations with the care of their patients. While we are excited about our accomplishments this quarter, we know we can do so much better in many ways and are excited about the enormous potential within our portfolio as we return to and exceed pre-COVID levels,” he added.





The Company noted that the strong results in the quarter came from continued improvements in census and managed care skilled mix across the portfolio, improved operational expense management, improved cash collections and the continuation of sequestration suspension and state-supported funding. Port noted that the Company saw continued sequential improvement in occupancy over the first quarter, with same store and transitioning occupancy both improving by 170 and 150 basis points, respectively. He also indicated that managed care census for the same store and transitioning portfolios increased by 33.9% and 27.9% from the prior year quarter, respectively.

“As the pent-up demand for healthcare services in our markets has continued to increase, our managed care skilled mix days and managed care average daily census improved again for an impressive fourth consecutive quarter. Also, our combined same store and transitioning managed care revenues for the quarter were up sequentially for the fourth quarter in a row. At the same time, our skilled mix has remained higher than pre-COVID levels, with a combined same store and transitioning skilled mix of 31.5% during the second quarter as compared to the first quarter of 2020, which was 29.3%. We are also very encouraged to see that some of our most mature markets, like most of Arizona and Colorado, have already returned to pre-COVID occupancy levels. We expect the positive trend in occupancy to continue throughout the year, subject to some seasonality, as volumes in higher acute settings and managed care utilizations continue to increase,” Port said.

Management raised the Company’s 2021 annual earnings guidance to $3.55 and $3.67 per diluted share, up from the previous guidance of $3.54 to $3.66 per diluted share, and affirmed its previous annual revenue guidance of $2.62 billion to $2.69 billion. The new midpoint of this 2021 earnings guidance represents an increase of 15.3% from the Company’s 2020 results and 102.8% higher than our 2019 results. Port noted that management is confident in this guidance due to the strong results during the first and second quarters and continued positive trends in occupancies. “While we are keenly aware of the potential resurgence of COVID in some of our markets, we remain confident that our local operators and their clinically-focused teams will rise to the challenge. If the new variant of the COVID virus persists, we have the ability to rely on the many, many lessons learned during the pandemic, including infection control procedures and treatment protocols. At the same time, we also have significantly more tools at our disposal than we did when the pandemic first arrived on the scene, including access to the vaccine and many forms of testing. In addition, we are grateful that the Federal Government has extended the State of Emergency to October 18, 2021, which keeps in place many of the regulatory and other forms of assistance helpful to patient care. When we consider the current health of our organization combined with our culture and proven local leadership strategy, we are confident that we are well-positioned to not only rebound to our pre-COVID path but to accelerate our growth,” Port added.

Chief Financial Officer, Suzanne Snapper emphasized that the results for the quarter do not include any benefit related to CARES Act Provider Relief Funds. The Company continued to return all of the provider relief funds it received from the Government, which to date totaled $153.2 million.

Ms. Snapper also reported that the company’s liquidity remains strong with approximately $198.4 million of cash on hand and $342.4 million of available capacity under its line-of-credit facility, which also has a built-in expansion option, both as of June 30, 2021. She also noted that the Company has 95 owned assets, 75 of which are unlevered and add additional liquidity.

Management’s guidance is based on diluted weighted average common shares outstanding of approximately 57.8 million and a 25% tax rate. In addition, the guidance assumes, among other things, normalized health insurance costs, normal anticipated Medicare and Medicaid reimbursement rate increases, net of provider taxes, and recovery of the COVID-19 pandemic. It also excludes acquisition-related costs and amortization costs related to intangible assets acquired, and share-based compensation.

A discussion of the company's use of non-GAAP financial measures is set forth below. A reconciliation of net income to EBITDA, adjusted EBITDAR, adjusted EBITDA, FFO for our real estate segment as well as a reconciliation of GAAP earnings per share, net income to adjusted net income and adjusted net earnings per share appear in the financial data portion of this release. More complete information is contained in the company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 which is expected to be filed with the SEC today and can be viewed on the company’s website at http://www.ensigngroup.net.

Growth and Real Estate Highlights

The Company’s affiliates ramped up its growth efforts in some of its most mature markets during the quarter. “We are thrilled about the fact that we have been able to add 17 operations to our organization since the pandemic began last year. When it would have been easy to hunker down and wait out the storm, we have maintained our disciplined march to responsible growth. Given our first priority is always to make sure our existing operations are strong, we have been extra diligent to ensure that each new addition had the full support of a healthy market, a proven leadership plan and a clear pathway to strong clinical and financial performance. Each of these new additions have been carefully selected and were acquired at attractive prices and terms. We are very excited to watch these operations become solid contributors to their clusters as they follow proven Ensign principles,” Chad Keetch, Ensign’s Chief Investment Officer, said.




The acquisitions during the quarter and since include the following skilled nursing operations:

Boulder Canyon Health and Rehabilitation, a 140-bed skilled nursing facility located in Boulder, Colorado;

Berthoud Care and Rehabilitation, a 76-bed skilled nursing facility located in Berthoud, Colorado;

South Valley Post Acute Rehabilitation, a 106-bed skilled nursing facility located in Denver, Colorado;

Windsor Rehabilitation and Healthcare, a 108-bed skilled nursing facility located in Terrell, Texas;

Mira Vista Care Center, a 94-bed skilled nursing facility located in Mount Vernon, Washington;

Shoreline Health and Rehabilitation, a 114-bed skilled nursing facility located in Shoreline, Washington;

The Oaks at Lakewood, a 80-bed skilled nursing facility located in Lakewood, Washington; and

The Oaks at Timberline, a 98-bed skilled nursing facility located in Vancouver, Washington.

These additions bring Ensign's growing portfolio to 240 healthcare operations, 22 of which also include senior living operations, across thirteen states. Ensign now owns 95 real estate assets, 65 of which it operates. Keetch also noted that the pipeline for Ensign’s typical turnaround opportunities remains strong. “We have a handful of deals that we expect to close yet this year and also expect some additional opportunities to come our way this fall. We have a lot of capacity to grow, including from a leadership and a capital perspective, but will always make sure we stay true to our principles of disciplined growth,” he added.

Turning to the Company’s real estate portfolio, Keetch added, “We have made significant progress in our effort to create a structure that will allow us to better demonstrate the growing value in our owned real estate and allows us to retain the ownership in our real estate. Since our last call our engaged advisors have helped us begin to prepare a structure inside of Ensign that highlights that value while not losing sight of our purpose-driven mission. We envision a structure that not only creates better visibility into the demonstrable value of our real estate, but also will provide us with an efficient vehicle for future acquisitions of properties that could be operated by Ensign affiliates or other third parties, which we believe will give us a new pathway to growth with transactions we would not have considered in the past. And even though we do not anticipate doing a public spin-off, one of our priorities in designing this entity is to create a structure that will preserve the optionality to access private and public markets in the future. We are very excited about the new opportunities embedded in this chapter of our growth story and expect to make a more detailed announcement regarding our real estate strategy next quarter,” Keetch said.

The Company continues to provide additional disclosure on our new real estate segment, which is comprised of properties owned by us and leased to affiliated skilled nursing and senior living operations and 31 senior living operations that are leased to The Pennant Group, Inc. Keetch noted that each of these properties are subject to triple-net, long-term leases and generated rental revenue of $16.0 million for the quarter, of which $12.1 million was derived from Ensign affiliated operations. Also, for the second quarter of 2021 Ensign reported $13.7 million in FFO, which represents an increase of 10.5% over the prior year quarter of $12.4 million.

Also, during the quarter, the company paid a quarterly cash dividend of $0.0525 per share of Ensign common stock. Keetch noted that the company’s liquidity remains strong and that the Company plans to continue its track record of paying dividends into the future.

Conference Call

A live webcast will be held Thursday, July 29, 2021 at 10:00 a.m. Pacific time (1:00 p.m. Eastern time) to discuss Ensign’s second quarter financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors Relations section of Ensign’s website at http://investor.ensigngroup.net. The webcast will be recorded, and will be available for replay via the website until 5:00 p.m. Pacific time on Friday, September 3, 2021.





About Ensign™

The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 240 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. As part of its investment strategy, the Company also acquire, lease and own healthcare real estate to service the post-acute care continuum through acquisition and investment opportunities in healthcare properties. Ensign’s new business venture operating subsidiaries also offer several other post-acute-related services, including mobile x-ray, non-emergency transportation services and other consulting services also across several states. Each of these operations is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Ensign Group, Inc. has direct operating assets, employees or revenue, or that any of the facilities, the Service Center or the captive insurance subsidiary are operated by the same entity. More information about Ensign is available at http://www.ensigngroup.net.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management’s current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance, and acquisition activities. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to the company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Additionally, our business and operations for 2021 continue to be impacted by the COVID-19 pandemic. Because of the unprecedented nature of the pandemic, we are unable to predict the full extent and duration of the financial impact of COVID-19 on our business, financial condition and results of operations. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the company’s periodic filings with the Securities and Exchange Commission, including its Form 10-K and Form 10-Q, for a more complete discussion of the risks and other factors that could affect Ensign’s business, prospects and any forward-looking statements. Except as required by the federal securities laws, Ensign does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

Contact Information
Investor/Media Relations, The Ensign Group, Inc., (949) 487-9500, ir@ensigngroup.net.
SOURCE: The Ensign Group, Inc.



THE ENSIGN GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME
Three Months Ended June 30,Six Months Ended June 30,
(In thousands, except per share data)2021202020212020
Revenue:
Service revenue$634,609 $581,079 $1,257,885 $1,167,030 
Rental revenue3,927 3,620 7,904 7,282 
Total revenue $638,536 $584,699 $1,265,789 $1,174,312 
Expense:
Cost of services488,524 451,749 970,710 906,270 
Rent—cost of services 34,455 32,484 67,911 64,814 
General and administrative expense36,908 31,427 71,181 63,676 
Depreciation and amortization13,795 13,605 27,454 27,325 
Total expenses573,682 529,265 1,137,256 1,062,085 
Income from operations64,854 55,434 128,533 112,227 
Other income (expense):
Interest expense(1,634)(2,293)(3,275)(5,958)
Interest and other income1,121 1,082 1,869 1,780 
Other expense, net(513)(1,211)(1,406)(4,178)
Income before provision for income taxes64,341 54,223 127,127 108,049 
Provision for income taxes13,758 13,535 26,707 26,159 
Net income 50,583 40,688 100,420 81,890 
Less: net income attributable to noncontrolling interests1,158 440 1,789 793 
Net income attributable to The Ensign Group, Inc.$49,425 $40,248 $98,631 $81,097 
Net income per share attributable to The Ensign Group, Inc.:
Basic $0.91 $0.76 $1.82 $1.52 
Diluted$0.87 $0.73 $1.73 $1.46 
Weighted average common shares outstanding:
Basic54,468 53,094 54,331 53,285 
Diluted56,997 55,181 56,945 55,489 




THE ENSIGN GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

June 30, 2021December 31, 2020
(In thousands)
Assets
Current assets:
Cash and cash equivalents$198,411 $236,562 
Accounts receivable—less allowance for doubtful accounts of $10,602 and $8,718 at June 30, 2021 and December 31, 2020, respectively313,663 305,062 
Investments—current10,573 13,449 
Prepaid income taxes8,814 1,224 
Prepaid expenses and other current assets35,643 26,659 
Total current assets567,104 582,956 
Property and equipment, net788,601 778,244 
Right-of-use assets 1,112,694 1,025,510 
Insurance subsidiary deposits and investments38,288 32,105 
Escrow deposits100 100 
Deferred tax assets32,396 32,424 
Restricted and other assets 42,496 33,155 
Intangible assets, net 2,784 2,899 
Goodwill 60,469 54,469 
Other indefinite-lived intangibles 3,621 3,716 
Total assets$2,648,553 $2,545,578 
Liabilities and equity
Current liabilities:
Accounts payable$58,700 $50,901 
Accrued wages and related liabilities225,455 236,614 
Lease liabilities—current 51,807 48,187 
Accrued self-insurance liabilities—current36,222 34,396 
Advance payment liabilities  102,023 
Other accrued liabilities 85,793 87,318 
Current maturities of long-term debt3,009 2,960 
Total current liabilities460,986 562,399 
Long-term debt—less current maturities111,287 112,544 
Long-term lease liabilities—less current portion 1,034,517 950,320 
Accrued self-insurance liabilities—less current portion66,556 62,402 
Other long-term liabilities46,564 39,686 
Total equity928,643 818,227 
Total liabilities and equity$2,648,553 $2,545,578 



THE ENSIGN GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS


The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented:
Six Months Ended June 30,
20212020
(In thousands)
Net cash provided by/(used in):
Operating activities$108,397 $174,138 
Investing activities(40,862)(28,326)
Financing activities(105,686)(3,249)
Net (decrease)/increase in cash and cash equivalents(38,151)142,563 
Cash and cash equivalents beginning of period236,562 59,175 
Cash and cash equivalents at end of period$198,411 $201,738 




THE ENSIGN GROUP, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands, except per share data)

RECONCILIATION OF GAAP TO NON-GAAP NET INCOME
The following table reconciles net income to Non-GAAP net income for the periods presented:
Three Months Ended June 30,Six Months Ended June 30,
2021202020212020
Net income $49,425 $40,248 $98,631 $81,097 
Non-GAAP adjustments
Stock-based compensation expense(a)4,633 3,528 8,687 6,763 
Results related to operations not at full capacity(b) 277 657 693 
Acquisition related costs(c)152 34 188 83 
Depreciation and amortization - patient base(d)15 20 27 233 
General and administrative -costs incurred related to real estate due diligence171 — 171 — 
General and administrative - costs incurred related to new systems implementation76 — 76 — 
Cost of services - gain on sale of assets — (540)— 
Provision for income taxes on Non-GAAP adjustments(e)(3,589)(986)(7,390)(2,795)
Non-GAAP income $50,883 $43,121 $100,507 $86,074 
Average number of diluted shares outstanding56,997 55,181 56,945 55,489 
Diluted Earnings Per Share
Net income$0.87 $0.73 $1.73 $1.46 
Adjusted Diluted Earnings Per Share
Net Income$0.89 $0.78 $1.76 $1.55 
Footnotes:
(a) Represents stock-based compensation expense incurred.
Three Months Ended June 30,Six Months Ended June 30,
2021202020212020
Cost of services$2,871 $2,326 $5,371 $4,437 
General and administrative1,762 1,202 3,316 2,326 
Total Non-GAAP adjustment$4,633 $3,528 $8,687 $6,763 
(b) Represents results to operations not at full capacity
Three Months Ended June 30,Six Months Ended June 30,
2021202020212020
Revenue$ $(535)$(456)$(1,264)
Cost of services 732 1,040 1,803 
Rent 25 38 47 
Depreciation and amortization 55 35 107 
Total Non-GAAP adjustment$ $277 $657 $693 
(c) Represents costs incurred to acquire an operation which are not capitalizable.
(d) Included in depreciation and amortization are expenses related to patient base intangible assets at newly acquired skilled nursing and senior living facilities.
(e) Represents an adjustment to the provision for income tax to our historical year to date effective tax rate of 25.0% for the three and six months ended June 30, 2021 and 2020.




THE ENSIGN GROUP, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(In thousands)

The table below reconciles net income to EBITDA, Adjusted EBITDA and Adjusted EBITDAR for the periods presented:
Three Months Ended June 30,Six Months Ended June 30,
2021202020212020
Consolidated Statements of Income Data:
Net income attributable to The Ensign Group, Inc.$50,583 $40,688 $100,420 $81,890 
Less: net income attributable to noncontrolling interests1,158 440 1,789 793 
Add: Interest expense, net513 1,211 1,406 4,178 
Provision for income taxes13,758 13,535 26,707 26,159 
Depreciation and amortization13,795 13,605 27,454 27,325 
EBITDA$77,491 $68,599 $154,198 $138,759 
Adjustments to EBITDA:
Stock-based compensation expense4,633 3,528 8,687 6,763 
Results related to operations not at full capacity(a) 197 584 539 
Gain on sale on assets — (540)— 
Costs incurred related to real estate due diligence171 — 171 — 
Acquisition related costs(b)152 34 188 83 
Costs incurred related to new systems implementation76 — 76 — 
Rent related to items above 25 38 47 
Adjusted EBITDA$82,523 $72,383 $163,402 $146,191 
Rent—cost of services34,455 32,484 67,911 64,814 
Less: rent related to items above (25)(38)(47)
Adjusted rent 34,455 32,459 67,873 64,767 
Adjusted EBITDAR $116,978 $231,275 
(a)    Represents results at closed operations and operations not at full capacity.
(b)    Costs incurred to acquire operations which are not capitalizable.


THE ENSIGN GROUP, INC.
UNAUDITED SELECT PERFORMANCE INDICATORS

The following tables summarize our selected performance indicators for our skilled services segment along with other statistics, for each of the dates or periods indicated:
Three Months Ended June 30,
 20212020Change% Change
Total Facility Results:(Dollars in thousands)  
Skilled services revenue$612,882 $556,677 $56,205 10.1 %
Number of facilities at period end209 195 14 7.2 %
Number of campuses at period end*22 21 4.8 %
Actual patient days(4)
1,599,707 1,530,286 69,421 4.5 %
Occupancy percentage — Operational beds72.7 %73.4 %(0.7)%
Skilled mix by nursing days30.9 %29.7 %1.2 %
Skilled mix by nursing revenue51.4 %51.4 %— %



Three Months Ended June 30,
 20212020Change% Change
Same Facility Results(1):(Dollars in thousands)  
Skilled services revenue$492,510 $468,023 $24,487 5.2 %
Number of facilities at period end165 165 — — %
Number of campuses at period end*15 15 — — %
Actual patient days1,264,220 1,262,224 1,996 0.2 %
Occupancy percentage — Operational beds73.9 %73.9 %— %
Skilled mix by nursing days32.4 %31.0 %1.4 %
Skilled mix by nursing revenue53.2 %52.8 %0.4 %
Three Months Ended June 30,
20212020Change% Change
Transitioning Facility Results(2):(Dollars in thousands)  
Skilled services revenue$88,617 $83,356 $5,261 6.3 %
Number of facilities at period end27 27 — — %
Number of campuses at period end*6 — — %
Actual patient days243,576 250,988 (7,412)(3.0)%
Occupancy percentage — Operational beds68.4 %70.9 %(2.5)%
Skilled mix by nursing days26.9 %24.0 %2.9 %
Skilled mix by nursing revenue46.3 %44.6 %1.7 %
Three Months Ended June 30,
20212020Change% Change
Recently Acquired Facility Results(3):(Dollars in thousands)  
Skilled services revenue$31,755 $5,298 $26,457 NM
Number of facilities at period end17 14 NM
Number of campuses at period end*1 — NM
Actual patient days91,911 17,074 74,837 NM
Occupancy percentage — Operational beds68.4 %76.0 %NM
Skilled mix by nursing days19.8 %15.9 %NM
Skilled mix by nursing revenue37.0 %30.0 %NM
* Campus represents a facility that offers both skilled nursing and senior living services. Revenue and expenses related to skilled nursing and senior living services have been allocated and recorded in the respective operating segment. In the second quarter of 2021, we converted a campus into a skilled nursing facility.
(1)Same Facility results represent all facilities purchased prior to January 1, 2018.
(2)Transitioning Facility results represent all facilities purchased from January 1, 2018 to December 31, 2019.
(3)Recently Acquired Facility (Acquisitions) results represent all facilities purchased on or subsequent to January 1, 2020.








Six Months Ended June 30,
 20212020Change% Change
Total Facility Results:(Dollars in thousands)  
Skilled services revenue$1,213,918 $1,114,981 $98,937 8.9 %
Number of facilities at period end209 195 14 7.2 %
Number of campuses at period end*22 21 4.8 %
Actual patient days3,109,307 3,173,676 (64,369)(2.0)%
Occupancy percentage — Operational beds71.9 %76.4 %(4.5)%
Skilled mix by nursing days32.6 %29.5 %3.1 %
Skilled mix by nursing revenue53.5 %50.8 %2.7 %
Six Months Ended June 30,
 20212020Change% Change
Same Facility Results(1):(Dollars in thousands)  
Skilled services revenue$984,300 $944,919 $39,381 4.2 %
Number of facilities at period end165 165 — — %
Number of campuses at period end*15 15 — — %
Actual patient days2,483,913 2,634,027 (150,114)(5.7)%
Occupancy percentage — Operational beds73.1 %77.1 %(4.0)%
Skilled mix by nursing days33.9 %31.0 %2.9 %
Skilled mix by nursing revenue54.9 %52.5 %2.4 %
Six Months Ended June 30,
20212020Change% Change
Transitioning Facility Results(2):(Dollars in thousands)  
Skilled services revenue$177,642 $162,383 $15,259 9.4 %
Number of facilities at period end27 27 — — %
Number of campuses at period end*6 — — %
Actual patient days479,244 514,329 (35,085)(6.8)%
Occupancy percentage — Operational beds67.6 %72.8 %(5.2)%
Skilled mix by nursing days28.7 %22.3 %6.4 %
Skilled mix by nursing revenue48.8 %41.7 %7.1 %
Six Months Ended June 30,
20212020Change% Change
Recently Acquired Facility Results(3):(Dollars in thousands)  
Skilled services revenue$51,976 $7,679 $44,297 NM
Number of facilities at period end17 14 NM
Number of campuses at period end*1 — NM
Actual patient days146,150 25,320 120,830 NM
Occupancy percentage — Operational beds67.8 %75.2 %NM
Skilled mix by nursing days22.9 %16.6 %NM
Skilled mix by nursing revenue41.9 %30.5 %NM
* Campus represents a facility that offers both skilled nursing and senior living services. Revenue and expenses related to skilled nursing and senior living services have been allocated and recorded in the respective operating segment. In the first half of 2021, we converted two campuses into two skilled nursing facilities.
(1)Same Facility results represent all facilities purchased prior to January 1, 2018.
(2)Transitioning Facility results represent all facilities purchased from January 1, 2018 to December 31, 2019.
(3)Recently Acquired Facility (Acquisitions) results represent all facilities purchased on or subsequent to January 1, 2020.




THE ENSIGN GROUP, INC.
SKILLED NURSING AVERAGE DAILY REVENUE RATES AND
PERCENT OF SKILLED NURSING REVENUE AND DAYS BY PAYOR
(Unaudited)

The following table reflects the change in skilled nursing average daily revenue rates by payor source, excluding services that are not covered by the daily rate(1):
Three Months Ended June 30,
 Same FacilityTransitioningAcquisitionsTotal
 20212020202120202021202020212020
Skilled Nursing Average Daily Revenue Rates:
Medicare$687.38 $665.84 $671.78 $639.97 $670.62 $574.22 $684.33 $661.05 
Managed care505.69 496.84 476.54 474.06 481.12 391.39 501.06 493.10 
Other skilled541.80 537.80 419.22 356.73 512.71 — 530.17 530.57 
Total skilled revenue584.52 587.36 559.34 565.08 582.65 534.44 581.11 584.08 
Medicaid248.71 236.36 238.66 223.11 242.40 236.81 246.65 234.02 
Private and other payors236.86 232.60 236.12 216.52 259.37 234.86 238.06 229.76 
Total skilled nursing revenue$356.45 $344.87 $324.54 $304.46 $311.41 $283.93 $349.00 $337.55 
(1) These rates exclude additional Federal Medical Assistance Percentage (FMAP) we recognized and include sequestration reversal of 2%.
.
Six Months Ended June 30,
 Same FacilityTransitioningAcquisitionsTotal
 20212020202120202021202020212020
Skilled Nursing Average Daily Revenue Rates:
Medicare$689.79 $664.78 $675.46 $634.74 $702.48 $551.59 $688.12 $659.51 
Managed care505.52 485.29 480.65 456.52 436.73 401.35 500.60 481.46 
Other skilled544.03 530.55 410.61 338.52 512.75 — 531.74 522.09 
Total skilled revenue589.97 573.61 568.53 549.01 592.65 517.00 587.15 570.34 
Medicaid250.01 233.78 240.10 221.07 241.82 235.53 247.95 231.54 
Private and other payors238.07 233.28 238.89 217.76 253.90 232.05 238.98 230.38 
Total skilled nursing revenue$364.03 $339.15 $334.18 $293.79 $323.27 $281.70 $357.51 $331.33 
(1) These rates exclude additional Federal Medical Assistance Percentage (FMAP) we recognized and include sequestration reversal of 2%.

The following tables set forth our percentage of skilled nursing patient revenue and days by payor source for the three and six months ended June 30, 2021 and 2020:
 Three Months Ended June 30,
 Same FacilityTransitioningAcquisitionsTotal
 20212020202120202021202020212020
Percentage of Skilled Nursing Revenue:
Medicare24.9 %29.5 %25.3 %29.4 %21.3 %25.2 %24.8 %29.5 %
Managed care19.5 14.8 17.2 13.9 8.8 4.8 18.6 14.6 
Other skilled8.8 8.5 3.8 1.3 6.9 — 8.0 7.3 
Skilled mix53.2 52.8 46.3 44.6 37.0 30.0 51.4 51.4 
Private and other payors6.8 7.5 7.8 8.7 8.7 13.1 7.0 7.7 
Medicaid40.0 39.7 45.9 46.7 54.3 56.9 41.6 40.9 
Total skilled nursing100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %



 Three Months Ended June 30,
 Same FacilityTransitioningAcquisitionsTotal
 20212020202120202021202020212020
Percentage of Skilled Nursing Days:
Medicare12.9 %15.3 %12.2 %14.0 %9.9 %12.5 %12.6 %15.1 %
Managed care13.7 10.3 11.7 8.9 5.7 3.4 13.0 10.0 
Other skilled5.8 5.4 3.0 1.1 4.2 — 5.3 4.6 
Skilled mix32.4 31.0 26.9 24.0 19.8 15.9 30.9 29.7 
Private and other payors10.3 11.0 10.8 12.3 10.4 15.9 10.3 11.3 
Medicaid57.3 58.0 62.3 63.7 69.8 68.2 58.8 59.0 
Total skilled nursing100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %

 Six Months Ended June 30,
 Same FacilityTransitioningAcquisitionsTotal
 20212020202120202021202020212020
Percentage of Skilled Nursing Revenue:
Medicare27.2 %27.3 %28.2 %26.8 %26.0 %25.1 %27.3 %27.2 %
Managed care19.2 16.9 17.3 13.5 7.8 5.4 18.5 16.3 
Other skilled8.5 8.3 3.3 1.4 8.1 — 7.7 7.3 
Skilled mix54.9 52.5 48.8 41.7 41.9 30.5 53.5 50.8 
Private and other payors6.4 7.5 7.4 9.6 8.0 15.7 6.5 7.9 
Medicaid38.7 40.0 43.8 48.7 50.1 53.8 40.0 41.3 
Total skilled nursing100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %

 Six Months Ended June 30,
 Same FacilityTransitioningAcquisitionsTotal
 20212020202120202021202020212020
Percentage of Skilled Nursing Days:
Medicare14.3 %13.9 %13.9 %12.4 %12.0 %12.8 %14.2 %13.7 %
Managed care13.9 11.8 12.0 8.7 5.8 3.8 13.2 11.2 
Other skilled5.7 5.3 2.8 1.2 5.1 — 5.2 4.6 
Skilled mix33.9 31.0 28.7 22.3 22.9 16.6 32.6 29.5 
Private and other payors9.7 11.0 10.4 13.0 10.2 19.1 9.8 11.4 
Medicaid56.4 58.0 60.9 64.7 66.9 64.3 57.6 59.1 
Total skilled nursing100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %




THE ENSIGN GROUP, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION BY SEGMENT
(In thousands)

Skilled Services

The table below reconciles net income to EBITDA and Adjusted EBITDA for the skilled services reportable segment for the periods presented:

Three Months Ended June 30,Six Months Ended June 30,
2021202020212020
Statements of Income Data:
Segment income(a)$90,010 $78,302 $178,941 $158,893 
Depreciation and amortization7,703 7,005 15,178 14,153 
EBITDA$97,713 $85,307 $194,119 $173,046 
Adjustments to EBITDA:
Stock-based compensation expense2,785 2,215 5,196 4,215 
Adjusted EBITDA$100,498 $87,522 $199,315 $177,261 
(a)    Segment income reflects profits or loss from operations before provision for income taxes, excluding gain or loss from sale of real estate, insurance recoveries and impairment charges from operations. General and administrative expenses are not allocated to any segment for purposes of determining segment profit or loss.

Real Estate
The following table sets forth details of operating results for our revenue and earnings, and their respective components, by our real estate segment for the periods indicated:
Three Months Ended June 30,Six Months Ended June 30,
2021202020212020
Rental revenue generated from third-party tenants$3,927 $3,620 $7,904 $7,282 
Rental revenue generated from Ensign affiliated operations12,104 11,389 24,006 22,671 
Total rental revenue16,031 15,009 31,910 29,953 
Segment income(a)8,891 7,794 17,712 14,119 
Depreciation and amortization4,784 4,587 9,477 9,102 
FFO(b)$13,675 $12,381 $27,189 $23,221 
(a) Segment income reflects profits or loss from operations before provision for income taxes, excluding gain or loss from sale of real estate, insurance recoveries and impairment charges from operations. General and administrative expenses are not allocated to any segment for purposes of determining segment profit or loss.
(b) FFO, in accordance with the definition used by the National Association of Real Estate Investment Trusts, means net income attributable to common stockholders, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate and impairment of depreciable real estate assets and including depreciation and amortization related to real estate to earnings.



THE ENSIGN GROUP, INC.
UNAUDITED REVENUE BY PAYOR SOURCE

The following table sets forth our service revenue by payor source and as a percentage of total service revenue for the periods indicated:
 Three Months Ended June 30,
20212020
Revenue% of RevenueRevenue% of Revenue
Medicaid(1)
$251,455 39.6 %$226,118 38.9 %
Medicare170,008 26.8 175,044 30.1 
Medicaid — skilled42,740 6.7 36,385 6.3 
Total Medicaid and Medicare464,203 73.1 437,547 75.3 
Managed care112,963 17.8 82,316 14.2 
Private and other(2)
57,443 9.1 61,216 10.5 
Service revenue$634,609 100.0 %$581,079 100.0 %
(1) Medicaid payor includes revenue for senior living operations and revenue related to FMAP for the three months ended June 30, 2021 and 2020.
(2) Private and other payors also includes revenue from all payors generated in other ancillary services for the three months ended June 30, 2021 and 2020.

 Six Months Ended June 30,
20212020
Revenue% of RevenueRevenue% of Revenue
Medicaid(1)
$482,813 38.4 %$450,314 38.6 %
Medicare360,311 28.6 330,628 28.3 
Medicaid — skilled82,733 6.6 72,394 6.2 
Total Medicaid and Medicare925,857 73.6 853,336 73.1 
Managed care221,308 17.6 184,345 15.8 
Private and other(2)
110,720 8.8 129,349 11.1 
Service revenue$1,257,885 100.0 %$1,167,030 100.0 %
(1) Medicaid payor includes revenue for senior living operations and revenue related to FMAP for the six months ended June 30, 2021 and 2020.
(2) Private and other payors also includes revenue from all payors generated in other ancillary services for the six months ended June 30, 2021 and 2020.




Discussion of Non-GAAP Financial Measures

EBITDA consists of net income before (a) interest expense, net, (b) provisions for income taxes and (c) depreciation and amortization. Adjusted EBITDA consists of net income before (a) interest expense, net, (b) provisions for income taxes, (c) depreciation and amortization, (d) stock-based compensation expense; (e) results of operations not at full capacity, excluding depreciation, interest and income taxes, (f) acquisition related costs, (g) gain on sale of assets, (h) costs incurred related to real estate due diligence and (i) costs incurred related to new systems implementation. Adjusted EBITDAR consists of net income before (a) interest expense, net, (b) provisions for income taxes, (c) depreciation and amortization, (d) rent-cost of services, (e) stock-based compensation expense; (f) results of operations not at full capacity, excluding rent, depreciation, interest and income taxes, (g) acquisition related costs, (h) gain on sale of assets, (i) costs incurred related to real estate due diligence and (j) costs incurred related to new systems implementation. Funds from Operations (FFO) for our real estate segment consists of segment income, excluding gains or losses from sales of real estate, insurance recoveries related to real estate and impairment of depreciable real estate assets and including depreciation and amortization related to real estate to earnings. The company believes that the presentation of EBITDA, adjusted EBITDA, FFO, adjusted net income and adjusted earnings per share provides important supplemental information to management and investors to evaluate the company’s operating performance. Adjusted EBITDAR is a financial valuation measure that is not specified in GAAP. This measure is not displayed as a performance measure as it excludes rent expense, which is a normal and recurring operating expense. The company believes disclosure of adjusted net income, adjusted net income per share, FFO, EBITDA, adjusted EBITDA and adjusted EBITDAR has substance because the excluded revenues and expenses are infrequent in nature and are variable in nature, or do not represent current revenues or cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the company believes that this non-GAAP measures provide useful information to investors, the specific manner in which management uses these measures, and some of the limitations associated with the use of these measures, please refer to the company's periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The company’s periodic filings are available on the SEC's website at www.sec.gov or under the "Financial Information" link of the Investor Relations section on Ensign’s website at http://www.ensigngroup.net.

EX-101.SCH 3 ensg-20210728.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Document link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ensg-20210728_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Trading Symbol Trading Symbol Document Period End Date Document Period End Date Soliciting Material Soliciting Material Document Type Document Type City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name Local Phone Number Local Phone Number Entity Address, City or Town Entity Address, City or Town Cover page. Cover [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 5 ensg-20210728_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 ensigngrouplogoa02a01a34.gif begin 644 ensigngrouplogoa02a01a34.gif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end XML 7 ensg-20210728_htm.xml IDEA: XBRL DOCUMENT 0001125376 2021-07-28 2021-07-28 0001125376 false 8-K 2021-07-28 Ensign Group, Inc DE 001-33757 33-0861263 29222 Rancho Viejo Road, Suite 127, San Juan Capistrano, CA 92675 949 487-9500 false false false false Common Stock, par value $0.001 per share ENSG NASDAQ false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover Document
Jul. 28, 2021
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jul. 28, 2021
Entity Registrant Name Ensign Group, Inc
Entity Incorporation, State or Country Code DE
Entity File Number 001-33757
Entity Tax Identification Number 33-0861263
Entity Address, Address Line One 29222 Rancho Viejo Road, Suite 127,
Entity Address, City or Town San Juan Capistrano,
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92675
City Area Code 949
Local Phone Number 487-9500
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol ENSG
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001125376
Amendment Flag false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Document Sheet http://www.ensigngroup.net/role/CoverDocument Cover Document Cover 1 false false All Reports Book All Reports ensg-20210728.htm ensg-20210728.xsd ensg-20210728_lab.xml ensg-20210728_pre.xml q22021pressrelease.htm http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ensg-20210728.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "ensg-20210728.htm" ] }, "labelLink": { "local": [ "ensg-20210728_lab.xml" ] }, "presentationLink": { "local": [ "ensg-20210728_pre.xml" ] }, "schema": { "local": [ "ensg-20210728.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ensg", "nsuri": "http://www.ensigngroup.net/20210728", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ensg-20210728.htm", "contextRef": "i8bb747fcb82241759c395eef20b0fbc3_D20210728-20210728", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Document", "role": "http://www.ensigngroup.net/role/CoverDocument", "shortName": "Cover Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ensg-20210728.htm", "contextRef": "i8bb747fcb82241759c395eef20b0fbc3_D20210728-20210728", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.ensigngroup.net/role/CoverDocument" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001125376-21-000126-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001125376-21-000126-xbrl.zip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